Taro Pharmaceutical Industries LtdNYSE:TARO
- LAST PRICE38.9800
- TODAY'S CHANGE (%)-0.1200 (-0.3069%)
- Bid / Lots37.6000/ 1
- Ask / Lots39.9000/ 2
- Open / Previous Close39.3800 / 39.1000
- Day Range
- 52 Week Range
- Volume37,983
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TARO |
|---|---|---|
| 09:32 ET | 173 | 39.38 |
| 10:06 ET | 195 | 39 |
| 10:19 ET | 100 | 39.17 |
| 10:30 ET | 100 | 39.17 |
| 10:32 ET | 200 | 38.61 |
| 10:44 ET | 100 | 39.16 |
| 10:46 ET | 1479 | 38.76 |
| 11:09 ET | 100 | 38.94 |
| 11:15 ET | 903 | 38.95 |
| 11:27 ET | 100 | 38.95 |
| 11:33 ET | 100 | 39.07 |
| 11:38 ET | 400 | 39 |
| 11:44 ET | 1030 | 39.24 |
| 11:49 ET | 100 | 39.245 |
| 12:05 ET | 300 | 39.265 |
| 12:07 ET | 300 | 39.26 |
| 12:12 ET | 100 | 39.26 |
| 12:16 ET | 400 | 39.145 |
| 12:18 ET | 142 | 39.17 |
| 12:34 ET | 200 | 39.305 |
| 12:36 ET | 1400 | 39 |
| 12:38 ET | 600 | 39.005 |
| 12:39 ET | 100 | 39 |
| 12:43 ET | 1068 | 39 |
| 12:48 ET | 100 | 38.99 |
| 12:59 ET | 500 | 39.005 |
| 01:24 ET | 408 | 39.005 |
| 01:30 ET | 100 | 39.05 |
| 01:44 ET | 200 | 39.165 |
| 01:48 ET | 1030 | 39 |
| 01:53 ET | 100 | 39 |
| 01:55 ET | 247 | 39 |
| 02:04 ET | 100 | 39.01 |
| 02:06 ET | 100 | 38.97 |
| 02:09 ET | 200 | 39 |
| 02:15 ET | 200 | 38.97 |
| 02:27 ET | 100 | 39.12 |
| 02:29 ET | 100 | 38.99 |
| 02:47 ET | 100 | 39.13 |
| 02:51 ET | 1393 | 39 |
| 02:56 ET | 336 | 39 |
| 03:07 ET | 100 | 39.025 |
| 03:12 ET | 100 | 39.05 |
| 03:18 ET | 100 | 39.025 |
| 03:20 ET | 457 | 39.075 |
| 03:25 ET | 100 | 39 |
| 03:27 ET | 100 | 39 |
| 03:32 ET | 443 | 39.08 |
| 03:36 ET | 300 | 39.03 |
| 03:39 ET | 100 | 39.19 |
| 03:43 ET | 588 | 39.14 |
| 03:45 ET | 2957 | 39 |
| 03:48 ET | 750 | 39.0211 |
| 03:50 ET | 450 | 38.9001 |
| 03:56 ET | 200 | 39.01 |
| 03:57 ET | 576 | 38.99 |
| 03:59 ET | 1927 | 38.98 |
May 30, 2023
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday, from 9:16AM ET on Tuesday May 30, 2023 by MT Newswires
9:16AM ET on Tuesday May 30, 2023 by MT NewswiresSector Update: Health Care, from 8:56AM ET on Tuesday May 30, 2023 by MT Newswires
8:56AM ET on Tuesday May 30, 2023 by MT NewswiresTaro Pharmaceutical Receives Takeover Offer From Sun Pharmaceutical for $38 Per Share in Cash, from 8:50AM ET on Tuesday May 30, 2023 by MT Newswires
8:50AM ET on Tuesday May 30, 2023 by MT NewswiresTop Premarket Gainers, from 7:48AM ET on Tuesday May 30, 2023 by MT Newswires
7:48AM ET on Tuesday May 30, 2023 by MT Newswires
May 23, 2023
BRIEF-Taro Says Q4 Earnings Per Share $0.18, from 7:32PM ET on Tuesday May 23, 2023 by Thomson Reuters
7:32PM ET on Tuesday May 23, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Taro Pharmaceutical Industries Ltd | 1.5B | 57.6x | -33.66% |
Tilray Brands Inc | 1.1B | -0.6x | --- |
Pacira Biosciences Inc | 1.8B | -133.3x | --- |
Amphastar Pharmaceuticals Inc | 2.2B | 25.8x | +87.41% |
Collegium Pharmaceutical Inc | 732.7M | -24.8x | --- |
Harmony Biosciences Holdings Inc | 2.2B | 11.8x | --- |
Company Information
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
Contact Information
- Headquarters
- 14 Hakitor Street, PO Box 10347HAIFA, Israel 2624761
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Dilip Shanghvi
- Chief Executive Officer, Director
- Uday Baldota
- Vice Chairman of the Board
- Abhay Gandhi
- Chief Financial Officer, Chief Accounting Officer, Vice President
- William Coote
- Director
- James Kedrowski
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
|---|---|
Revenue (TTM) | $573.0M |
Shares Outstanding | 37.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $0.68 |
Book Value | $38.36 |
P/E Ratio | 57.6x |
Price/Sales (TTM) | 2.6 |
Price/Cash Flow (TTM) | 25.5x |
Operating Margin | 3.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
